Biotech and Pharma industry experts converse on deal making trends. Learn how you can position your technology and/or company for success in the current environment.
Our seasoned panel discusses the evolution of deal models in the life science industry from the 1980s to present day. Our panelists touch upon issues relating to the size of the deals, valuations, early stage /late stage deals, and recent acquisition activity (Takeda/Millennium; AstraZeneca/MedImmune; Imclone/Lilly). A must watch for anyone interested in Biotech Pharma deal making.
Moderator:
- Dr. Mark DeWyngaert - MD Huron Consulting Group
Panelists:
- Dr. Christine T. Fischette, President, Enzo Therapeutics, Inc.
- Tamar D. Howson, MS, MBA, JSB Partners
- Ed Saltzman, President, DefinedHealth
Link to this comment:
All Comments (0)